StockWatch
·
Q2 FY-2027 RESULTS · CHOLAHLDNG

Chola Financial Holdings: consol PAT +25% YoY to ₹1,520 Cr, NBFC offsets insurer loss

PAT +25.19% YoY · revenue +18.9% · margins expanding

Q2 FY27 resultsCHOLAHLDNGCholamandalam Financial Holdings Ltd06 Nov 2026 · 3 min read
Revenue

₹11,264.41 Cr

+18.9% YoY

PAT (consolidated)

₹1,520.11 Cr

+25.19% YoY

Net margin

13.35%

+0.7pp YoY

EPS

₹34.22

On a consolidated basis (primary, per CFHL's group structure), Cholamandalam Financial Holdings reported PAT of ₹1,520 Cr for Q2 FY27, up 25% YoY from ₹1,214 Cr, on consolidated total income of ₹11,388 Cr, up 19% YoY from ₹9,578 Cr. Sequentially PAT fell 15% from Q1 FY27's ₹1,789 Cr — a reversal driven almost entirely by the insurance subsidiary, not the core lending franchise. Standalone (holdco-only) PAT was ₹27.89 Cr versus ₹27.16 Cr a year ago, essentially flat, as expected for a dividend/service-fee-driven parent entity; the consolidated print is what matters for the group story. No exceptional item appears on the face of either P&L this quarter or last, so no formal adjusted-growth figure applies.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹11,264.41 Cr+1.4%+18.7%
Expenses₹9,358.78 Cr+6.2%+17.2%
PAT₹1,520.11 Cr-15.03%+25.19%
Net margin13.35%-2.6pp+0.7pp
EPS₹34.22-20.3%+16.9%

NBFC subsidiary CIFCL (CFHL holds ~43.48%) remained the growth engine: standalone PAT rose 41% YoY to ₹1,630 Cr on disbursements up 47% YoY to ₹35,872 Cr and AUM up 23% YoY to ₹2,68,009 Cr, with Financing segment PBT at ₹2,187 Cr (+40% YoY). That strength was partly offset by CMSGICL (general insurance, ~60% stake), which swung to a ₹120 Cr post-tax loss versus a ₹46 Cr profit a year ago — H1 FY27 PAT collapsed to ₹8 Cr from ₹165 Cr — on NATCAT (natural catastrophe) claims in H1 FY27 and elevated Motor OD claims experience; segment PBT for Insurance moved to a ₹169 Cr loss from a ₹62 Cr profit a year ago. Consolidated NPM was 13.35%, up modestly from 12.68% a year ago but down sharply from ~16.0% in Q1 FY27 — the sequential compression is the insurance loss flowing into the group number.

₹
1,206.831,328.941,451.051,573.161,695.271,455.908-0308-2509-1710-1211-0411-06Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,455.9, up 3.8% over the past month of trading.

₹ Cr
0667.891,335.782,003.671,259.54Q1 FY26rev ₹9,296 Cr1,214.27Q2 FY26rev ₹9,487 Cr1,385.82Q3 FY26rev ₹9,949 Cr1,625.55Q4 FY26rev ₹10,444 Cr1,788.99Q1 FY27rev ₹11,114 Cr1,520.11Q2 FY27rev ₹11,264 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
No formal quantified guidance issued. Management targets motor OD loss ratio to high-70s range over 'couple of quarters' (no firm timeline). IFRS transition effective April 1, 2027; impact on profitability unclear, clarity expected Q2 FY2027.

— This quarter: missed

Against management's own prior guidance (Aug 2026 call), CFHL/CIFCL had targeted bringing the Motor OD loss ratio down to the high-70s "over a couple of quarters," with no firm date; this quarter's elevated claims and the insurer's swing to a loss indicate that improvement has not yet shown up, an early miss against the guided direction even allowing for the open timeline. Management had also flagged that clarity on the IFRS transition (effective April 1, 2027) was expected this quarter; this filing and the accompanying press release carry no update on that front. No specific pre-result street consensus for CFHL's or CIFCL's Q2 FY27 PAT could be located, so vsStreet is unknown; available post-result brokerage coverage (e.g., PL) confirms the reported numbers rather than a prior estimate. Among the quarter's other developments, CMSGICL's own press release disclosed an investment book of ₹18,937 Cr and 7% YoY GWP growth to ₹2,429 Cr even as underwriting profitability fell; a 0.016% stake pickup by Bandhan MF and the routine trading-window closure are not financially material.

  • W1

    Motor OD loss ratio trajectory at CMSGICL — guided to high-70s 'over a couple of quarters' from the Aug 2026 call; this quarter showed elevated claims instead, so Q3 FY27 is the next checkpoint

  • W2

    CMSGICL NATCAT-driven loss recovery — H1 FY27 PAT fell to ₹8 Cr from ₹165 Cr; watch whether H2 reverses as catastrophe-claim seasonality fades

  • W3

    IFRS transition clarity (effective April 1, 2027) — management had flagged clarity expected this quarter; no update appeared in this filing, so watch Q3 disclosure

Informational and educational content only. Not investment advice.